Literature DB >> 23027916

Management of borderline personality disorder.

Robert S Biskin1, Joel Paris.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23027916      PMCID： PMC3503902          DOI： 10.1503/cmaj.112055

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  44 in total

1.  Treatment histories of borderline inpatients.

Authors:  M C Zanarini; F R Frankenburg; G S Khera; J Bleichmar
Journal:  Compr Psychiatry       Date:  2001 Mar-Apr       Impact factor: 3.735

2.  Risk factors and correlates of violence among acutely ill adult psychiatric inpatients.

Authors:  A E Soliman; H Reza
Journal:  Psychiatr Serv       Date:  2001-01       Impact factor: 3.084

3.  A 27-year follow-up of patients with borderline personality disorder.

Authors:  J Paris; H Zweig-Frank
Journal:  Compr Psychiatry       Date:  2001 Nov-Dec       Impact factor: 3.735

4.  Estimating the prevalence of personality disorders in the community.

Authors:  Joel Paris
Journal:  J Pers Disord       Date:  2010-08

5.  Dialectical behavior therapy for borderline personality disorder: a meta-analysis using mixed-effects modeling.

Authors:  Sören Kliem; Christoph Kröger; Joachim Kosfelder
Journal:  J Consult Clin Psychol       Date:  2010-12

6.  Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence.

Authors:  M M Linehan; H Schmidt; L A Dimeff; J C Craft; J Kanter; K A Comtois
Journal:  Am J Addict       Date:  1999

7.  Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up.

Authors:  A Bateman; P Fonagy
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

8.  Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder--a prospective study.

Authors:  M Bohus; B Haaf; C Stiglmayr; U Pohl; R Böhme; M Linehan
Journal:  Behav Res Ther       Date:  2000-09

9.  A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.

Authors:  Mary C Zanarini; S Charles Schulz; Holland C Detke; Yoko Tanaka; Fangyi Zhao; Daniel Lin; Walter Deberdt; Ludmila Kryzhanovskaya; Sara Corya
Journal:  J Clin Psychiatry       Date:  2011-10       Impact factor: 4.384

10.  A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder.

Authors:  Shelley F McMain; Paul S Links; William H Gnam; Tim Guimond; Robert J Cardish; Lorne Korman; David L Streiner
Journal:  Am J Psychiatry       Date:  2009-09-15       Impact factor: 18.112
View more
  9 in total

1.  Treatment of borderline personality disorder in youth.

Authors:  Robert S Biskin
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

Review 2.  Diagnosing borderline personality disorder.

Authors:  Robert S Biskin; Joel Paris
Journal:  CMAJ       Date:  2012-09-17       Impact factor: 8.262

3.  Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis.

Authors:  Jennifer Wong; Anees Bahji; Sarosh Khalid-Khan
Journal:  Can J Psychiatry       Date:  2019-09-26       Impact factor: 4.356

Review 4.  The Use of Computer-Driven Technologies in the Treatment of Borderline Personality Disorder: A Systematic Review.

Authors:  Alexandre Hudon; Caroline Gaudreau-Ménard; Marissa Bouchard-Boivin; Francis Godin; Lionel Cailhol
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

5.  The Relationship Between Trauma Exposure and Adult Tobacco Use: Analysis of the National Epidemiologic Survey on Alcohol and Related Conditions (III).

Authors:  Alexandra Budenz; Amanda Klein; Yvonne Prutzman
Journal:  Nicotine Tob Res       Date:  2021-08-29       Impact factor: 4.244

Review 6.  Borderline personality disorder in adolescents: the He-who-must-not-be-named of psychiatry.

Authors:  Marie-Pier Larrivée
Journal:  Dialogues Clin Neurosci       Date:  2013-06       Impact factor: 5.986

7.  Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).

Authors:  Márcio G Soeiro-DE-Souza; Vasco Videira Dias; Giovanni Missio; Vicent Balanzá-Martinez; Leandro Valiengo; André F Carvalho; Ricardo Alberto Moreno
Journal:  Exp Ther Med       Date:  2015-01-23       Impact factor: 2.447

8.  A standardized crisis management model for self-harming and suicidal individuals with three or more diagnostic criteria of borderline personality disorder: The Brief Admission Skåne randomized controlled trial protocol (BASRCT).

Authors:  Sophie I Liljedahl; Marjolein Helleman; Daiva Daukantaité; Åsa Westrin; Sofie Westling
Journal:  BMC Psychiatry       Date:  2017-06-15       Impact factor: 3.630

9.  Dialectical behavior therapy as treatment for borderline personality disorder.

Authors:  Jennifer M May; Toni M Richardi; Kelly S Barth
Journal:  Ment Health Clin       Date:  2016-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.